NONPARTISAN · SOURCED FROM CONGRESS.GOV, OPENFEC, SENATE & HOUSE CLERKS · UPDATED REGULARLY
119th Congress · House bill · Last action Sep 19, 2025
Bills›Health›H.R. 5526Congress.gov ↗
H.R. 5526In CommitteeHealth

Biosimilar Red Tape Elimination Act

Sponsor: Rep. Pfluger, August [R-TX-11] (R-TX)8 cosponsorsIntroduced Sep 19, 2025
✆
In plain English

A plain-English summary will be generated the next time this page is viewed by an admin.

Where it is in the process

✓
Introduced
Sep 19
✓
House committee
Sep 19
3
House floor
-
4
Senate
-
5
Signed
-
What happens next: Sits in committee. Needs a markup or favorable report to advance to the House floor.

Sponsor

Cosponsors (8)

GR
JR
DR
GR
BR
RR
BR
+1
4 Democrats, 4 Republicans (of 8 shown).

Activity timeline

Sep 19
Referred to the House Committee on Energy and Commerce.
Sep 19
Introduced in House
Sep 19
Introduced in House
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Read full text →

Full action log

All 3 recorded actions since introduction · Source: Congress.gov
Sep 19
HOUSEReferred to the House Committee on Energy and Commerce.
Sep 19
Introduced in House
Sep 19
Introduced in House

All 8 cosponsors

4 Democrats · 4 Republicans
Democrats (4)
Republicans (4)

In the news

How cutting red tape could lower prescription drug prices - PIRG
Stark Law & Mailing Physician-Dispensed Prescriptions: From COVID-19 Waivers to Federal Legislative Action - The National Law Review
House Unanimously Passes Seniors’ Access to Critical Medications Act - The American Journal of Managed Care
San Nicolas wants territories represented in Senate, too - The Guam Daily Post
Track this bill
Get an alert when it moves to the next stage or gets a vote.